Search clinical trials for: Invasive Candidiasis

Total 6866 results

University Hospital, Limoges

Completed

Pharmacokinetics of Micafungin in Patients of Intensive Care Units (MI-K)

Invasive Candidiasis

France
Astellas Pharma China, Inc.

Terminated

A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

Candidemia | Candidiasis

China
Pfizer

Completed

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV

Candidemia | Other Forms of Candida Infections(Intra-abdominal Abscess, Peritonitis)

Korea, Republic of
Astellas Pharma Singapore Pte. Ltd.

Completed

Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study

Invasive Fungal Infections

Hong Kong, Korea, Republic of, Singapore, Taiwan, Thailand
Centre Hospitalier Universitaire Dijon

Unknown

Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk Patients (CAHOHR)

Candidemia of C. Glabrata

France
Merck Sharp & Dohme LLC

Completed

A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)

Candidiasis, Invasive | Aspergillosis | Candidiasis, Esophageal
Hasan Al-Dorzi
King Fahad Medical City

Completed

Invasive Candidiasis in Saudi ICUs (ICIP-SA)

Invasive Candidiasis

Saudi Arabia
T2 Biosystems

Completed

Serial Therapeutic and Antifungal Monitoring Protocol (STAMP)

Candidemia

United States
Astellas Pharma Inc

Completed

Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Candidemia | Invasive Candidiasis | Esophageal Candidiasis | Oropharyngeal Candidiasis

United States, South Africa
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaborators

Completed

Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis (CANHPARI)

Neutropenia | Hematopoietic Stem Cell Transplantation | Hematological Malignancies | Invasive Fungal Disease | Chronic Disseminated Candidiasis

France
Astellas Pharma Inc

Completed

Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis

Candidiasis

United Kingdom, Austria, France, Germany, Italy, Poland, Spain, Sweden
Astellas Pharma Inc

Completed

A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects (INTENSE)

Mycoses

Belgium, Germany, Spain, France, Italy, Turkey, Austria, Switzerland, Hungary, United Kingdom, Israel, Denmark, Greece, Finland, Romania
University Medical Center Groningen

Completed

Variability of Fluconazole Concentration in Critically Ill Patients

Invasive Candidiasis

Netherlands
Outcome Rea
Assistance Publique - Hôpitaux de Paris

Completed

Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients (CASPOLOAD)

Candida Infections

France
Merck Sharp & Dohme LLC

Completed

A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)

Invasive Candidiasis
Merck Sharp & Dohme LLC
Mycoses Study Group

Terminated

Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)

Invasive Candidiasis
Merck Sharp & Dohme LLC

Completed

A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)

Fungal Infection
Merck Sharp & Dohme LLC

Completed

Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)

Infection, Invasive Fungal
Merck Sharp & Dohme LLC

Completed

Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)

Mycoses
Merck Sharp & Dohme LLC

Completed

Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)

Mycoses
University Medical Center Groningen

Completed

Pharmacokinetics of Micafungin in Critically Ill Patients

Critical Illness | Invasive Candidiasis

Netherlands
Merck Sharp & Dohme LLC
Federal University of São Paulo

Completed

A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)

Candidemia
Pfizer

Terminated

A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients

Candidiasis

Hong Kong, Hungary, China, Czech Republic, Mexico, Philippines, Poland, Slovakia
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Bio-assay Development and Implementation for Fungal Infection Detection

Candidemia
Pfizer

Terminated

Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins

Candidemia | Invasive Candidiasis
Merck Sharp & Dohme LLC

Completed

PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)

Mycoses
University Medical Center Groningen

Completed

Optimal Dosage of Caspofungin in Critically Ill Patients

Critically Ill | Suspected Invasive Candidiasis

Netherlands
Pfizer

Terminated

A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis

Candidemia

China
University of Arkansas

Withdrawn

UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients

Candidemia | Aspergillosis | C. Difficile

United States
AM-Pharma

Withdrawn

A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia (SLIC)

Candidaemia

Netherlands
Robert Krause, MD

Completed

Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?

Invasive Candidiasis | Pulmonary Candidiasis

Austria
University Hospital, Grenoble

Completed

Empirical Antifungal Treatment in ICUS (EMPIRICUS)

Invasive Candidiasis

France
Duke University
Pfizer

Completed

β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients

Invasive Candidiasis

United States
Giovanni Di Perri
Merck Sharp & Dohme LLC

Completed

Early- and Late-onset Candidemia

Candidemia

Italy
Society of Indian Human & Animal Mycologist

Completed

SIHAM Candidemia Network:An Observational Study

Candidemia

India
Astellas Pharma Inc

Completed

Study of Micafungin in Patients With Invasive Candidiasis or Candidemia

Candidemia | Candidiasis

Belgium, France, Germany, Spain, United States, India, Canada, Brazil, Switzerland, Austria, Croatia, Netherlands, Poland, Czech Republic, United Kingdom
Astellas Pharma Inc

Completed

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

Candidiasis

United States, Canada
Astellas Pharma Inc

Completed

Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Candidemia | Invasive Candidiasis | Esophageal Candidiasis | Oropharyngeal Candidiasis

United States
University of Houston
Merck Sharp & Dohme LLC

Completed

Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility

Candida | Blood Stream Infections
T2 Biosystems

Completed

Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT) (DIRECT)

Candidemia

United States
T2 Biosystems

Completed

Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study) (direcT2)

Candidemia

United States
Hacettepe University

Completed

Candidemia in a Pediatric Center and Importance of Central Venous Catheter Removal

Candidemia

Turkey
Pfizer

Terminated

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida

Candidiasis | Fungemia

Belgium, United States, Canada, Switzerland, Netherlands, Bulgaria, Portugal, Romania, Russian Federation
Fundacion SEIMC-GESIDA
Merck Sharp & Dohme LLC; Pfizer; Gilead Sciences; Astellas Pharma Inc

Completed

Prospective Population Study on Candidemia in Spain (CANDIPOP)

Fungemia

Spain
Pfizer

Terminated

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System

Candidiasis | Fungemia | Neutropenia

Poland, Russian Federation, France, Bosnia and Herzegovina, Italy, Slovakia
Bristol-Myers Squibb

Completed

Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants

Sepsis | Candidemia | Staphylococcal Infections | Nosocomial Infections

United States, Canada
University Medical Center Groningen

Completed

Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)

Critically Ill | Invasive Candidiasis

Netherlands
Elisabethinen Hospital
Pfizer

Terminated

Anidulafungin in Patients With Hematologic Malignancies (ECALTA)

Hematologic Malignancies

Austria
Radboud University Medical Center
BioMérieux

Unknown

Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia

Candidemia

Netherlands
Pfizer

Completed

Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis

Candidiasis

United States, Korea, Republic of

3

Subscribe